$HUM

Glenmark Pharmaceuticals said its U.S. subsidiary, Glenmark USA, agreed to settle with Humana Inc. for $15.28 million, including interest, to resolve antitrust and consumer protection claims over alleged generic drug price-fixing and market allocation. Glenmark USA denies all allegations. The company said the amount is already provided for in its financials and expects no significant financial impact.

Humana (HUM) shares rose 1.1% to $389.05 after a Medicare Advantage reset affects about 600,000 members. Humana expects to retain 40% via other products, implying potential net attrition near 360,000. The article cites Q2 revenue up 26.2% to $40.87B and adjusted EPS $7.61, with a goal of at least 3% pretax margin in 2028.

Humana (NYSE: HUM) said it will exit Medicare Advantage plans covering about 600,000 members in 2027, with letters to be sent in September, according to its July 29, 2026 earnings call. The company expects to recapture about 40% of the volume. Affected members may have a 63-day Medigap guaranteed-issue window after coverage ends.

Humana and UnitedHealth are trimming Medicare Advantage coverage as costs rise. Humana said it will remove more than 500,000 seniors from plans next year for the second straight year, while UnitedHealth is cutting a similar number of plans and enrollees. KFF data cited by the article says cuts are mainly in rural areas, including Wyoming, the Dakotas, New Hampshire, and Vermont.

A Q2 earnings roundup covers health insurers and related providers. CVS Health (CVS) reported $106.1B revenue (+7.3% YoY), beating EPS and full-year EPS guidance; shares fell 8.4% to $95.66. Progyny (PGNY) revenue was $350.5M (+5.3%), but guidance missed; stock down 7.8% to $27.87. Humana (HUM) revenue $40.87B (+26.2%) and Clover Health (CLOV) revenue $743.2M (+55.6%) both beat; CLOV rose 9.9% to $4.55.

Humana said it will exit certain Medicare Advantage plans covering about 600,000 members in 2027, about 8% of its 7.2 million Medicare Advantage customers, and expects to re-enroll about 40% of those members into other plans. The article cites Johns Hopkins research that about 2.9 million members were displaced ahead of 2026.

Cityblock Health said it has partnered with Humana to provide wraparound care management in North Carolina for nearly 20,000 Humana Medicare Advantage and dually eligible members starting July 1. Cityblock will deliver in-person and virtual primary, urgent, and behavioral health services and coordinate with primary care teams and Humana, according to an announcement.

Glenmark Pharmaceuticals’ U.S. unit said, in an exchange filing, it reached a settlement with Humana to resolve antitrust litigation tied to consolidated generic-drug price-fixing claims in the Eastern District of Pennsylvania. The settlement totals $15.28 million plus interest, paid in two installments. Glenmark denied the allegations and said the amount was already booked in its financial statements.

Glenmark Pharmaceuticals Limited said it will pay Humana, Inc. $15.28 million to settle a subset of consolidated antitrust and consumer protection lawsuits in the Eastern District of Pennsylvania. The claims involved alleged price-fixing and market allocation for generic drugs. Glenmark said the settlement does not admit liability and the amount was already provided for in its financials. It also scheduled investor meetings in Mumbai in Aug-Sep 2026.

Glenmark Pharmaceuticals Ltd said its US unit, Glenmark Pharmaceuticals Inc., agreed to pay Humana Inc. $15.28 million to settle antitrust litigation over alleged price-fixing and market allocation in generic drugs. Glenmark said it denies all allegations and the settlement is not an admission of liability. The payment is in two installments and already provided for in its financials.